ImCheck Therapeutics competitorsClear all

ImCheck Therapeutics's top competitors include Pandion Therapeutics, MedDay, Carmot Therapeutics and Rubius Therapeutics.
ImCheck Therapeutics
ImCheck Therapeutics
ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
Pandion Therapeutics
Pandion Therapeutics
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
MedDay
MedDay
MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.
Carmot Therapeutics
Carmot Therapeutics
Carmot Therapeutics is a biotech company focused on the discovery of innovative drugs for the treatment of metabolic diseases, cancer, and inflammation.
Rubius Therapeutics
Rubius Therapeutics
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
Founding Date
Founding Date
2015
Founding Date
2017
Founding Date
2011
Founding Date
2008
Founding Date
2013
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Marseille, FR HQ
Locations
Cambridge, US HQ
Watertown, US
Locations
Clichy, FR HQ
Paris, FR
Boston, US
Locations
Berkeley, US HQ
San Francisco, US
Locations
Cambridge, US HQ
Smithfield, US
Employees
Employees
39
Employees
665% increase
Employees
476% decrease
Employees
2
Employees
17423% increase
Twitter followers
Twitter followers
446
Twitter followers
266
Twitter followers
229
Twitter followers
N/A
Twitter followers
1.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
22
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
6.7
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
91.67%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
329753
Alexa Website Rank
N/A
Alexa Website Rank
291923
Alexa Website Rank
339837

Funding

Latest funding round
Latest funding round
$ 53.2m (over 1 year ago)
Latest funding round
$ 80m (about 1 year ago)
Latest funding round
$ 38.5m (about 5 years ago)
Latest funding round
$ 47m (7 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 76.1m
Total funding raised
$ 138m
Total funding raised
$ 48.9m
Total funding raised
$ 74.8m
Total funding raised
$ 245m
For sources of this data, please see the company profile

View company profiles

Pandion Therapeutics
HQ
Cambridge, US
Employees
66↑ 5% increase

Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.

View company
MedDay
HQ
Clichy, FR
Employees
47↓ 6% decrease

MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.

View company
Carmot Therapeutics
HQ
Berkeley, US
Employees
2

Carmot Therapeutics is a biotech company focused on the discovery of innovative drugs for the treatment of metabolic diseases, cancer, and inflammation.

View company
Rubius Therapeutics
HQ
Cambridge, US
Employees
174↑ 23% increase

Rubius is developing a new class of drugs, Red-Cell Therapeutics™.

View company